aurora kinase inhibitors (University of Central Florida)

N/A

Report date: 2025/03/14 16:39:41
NME

Base Information

Drug Nameaurora kinase inhibitors (University of Central Florida)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Aurora inhibitors
TargetsSerine/threonine-protein kinase Aurora
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Central Florida
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Central Florida Office of Research and CommercializationUniversity of Central Florida
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A